Dr. Sheg Oluwaseun Aranmolate, MD

Dr. Aranmolate practices at Vohra Wound Physicians - Miramar in Minneapolis, Minnesota.

Dr. Aranmolate's NPI, 1528488699, was assigned on April 16, 2014. Dr. Aranmolate graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2014. Dr. Aranmolate holds Tennessee license 53617.

Dr. Aranmolate's primary practice is Vohra Wound Physicians - Miramar, at 618 17th E St, Minneapolis, MN 55404 in Hennepin County. The practice phone is (877) 866-7123.

Dr. Aranmolate's primary practice is Vohra Wound Physicians - Miramar in Minneapolis, Minnesota. Dr. Aranmolate is also affiliated with Select Specialty Hospital - West Tennessee. The medical group on file is Signify Health. Dmand AI also links Dr. Aranmolate to 3 more group practices and clinics, 3 medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aranmolate practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Aranmolate's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dmand AI has Dr. Aranmolate's licenses on file in 4 states: Tennessee, Florida, Georgia and North Carolina.

Dmand AI lists chronic diabetes, chronic embolism thrombosis, chronic skin ulcer, mobility impairment, peripheral vascular disease and varicose veins among the conditions Dr. Aranmolate treats.

CMS data shows 6,634 Medicare services from Dr. Aranmolate across 18 procedure codes in 2024, for 353 Medicare patients. Medicare paid $2,384,161 for them.

CMS counts 353 Medicare patients who saw Dr. Aranmolate in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 3.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aranmolate's median patient age at 76, with 59% women.

In 2024, Dr. Aranmolate wrote 338 Medicare Part D claims for 88 patients. 37% of them were for generic drugs. CMS names the drug for 322 of them, across 4 drugs with 11 or more claims each, at $7,983 in total drug cost. In 2023, CMS named 178 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Aranmolate for performance year 2024, reported as part of a group. Dr. Aranmolate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aranmolate as offering telehealth. CMS counts 1,133 procedures of removal of tissue by Dr. Aranmolate, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Aranmolate, published from 2013 to 2016. Dr. Aranmolate's most frequent co-authors are Ahmed S. Attia, MD and James Edward Cassat, MD, PhD.

CMS Open Payments shows 1 general payment to Dr. Aranmolate from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Smith & Nephew, Inc. paid the most, $37.

Dr. Aranmolate graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2014.

Dr. Aranmolate is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Cigna and Highmark. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.